Filed: 5/14/2024ACC: 0001104659-24-060707
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $745.65M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$745.65M
Total AUM (reported)
38.83M
Total Shares
Allocation by class
COM$714.81M95.9%
SHS$17.70M2.4%
CL A COM$7.35M1.0%
ADR$4.84M0.6%
COM CL A$945.9K0.1%
Portfolio Concentration
Top 3$602.45M80.8%
4–10$93.93M12.6%
11–25$49.26M6.6%
Top 3 weight
80.8%
Top 10 weight
93.4%
Voting Authority Distribution
Total shares with voting rights: 38.83M
Sole
Full voting authority
38.83M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
Alpine Immune Sciences, Inc.
SOLEShares8.32M
TypeSH
Market value$329.72M
44.22%
Sole
8.32M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares5.46M
TypeSH
Market value$239.64M
32.14%
Sole
5.46M
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares2.10M
TypeSH
Market value$33.09M
4.44%
Sole
2.10M
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares129.07K
TypeSH
Market value$17.72M
2.38%
Sole
129.07K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.96M
TypeSH
Market value$17.70M
2.37%
Sole
4.96M
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares869.79K
TypeSH
Market value$16.42M
2.20%
Sole
869.79K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares65.77K
TypeSH
Market value$11.70M
1.57%
Sole
65.77K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares347.83K
TypeSH
Market value$11.08M
1.49%
Sole
347.83K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$10.27M
1.38%
Sole
4.45M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares850K
TypeSH
Market value$9.03M
1.21%
Sole
850K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares166.60K
TypeSH
Market value$8.37M
1.12%
Sole
166.60K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares157.96K
TypeSH
Market value$7.39M
0.99%
Sole
157.96K
Shared
0.00
None
0.00
10x Genomics, Inc.
SOLEShares195.84K
TypeSH
Market value$7.35M
0.99%
Sole
195.84K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares94.04K
TypeSH
Market value$6.59M
0.88%
Sole
94.04K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP-ADR
SOLEShares86.36K
TypeSH
Market value$4.84M
0.65%
Sole
86.36K
Shared
0.00
None
0.00
MERUS NV
SOLEShares101.80K
TypeSH
Market value$4.58M
0.61%
Sole
101.80K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$4.05M
0.54%
Sole
515.55K
Shared
0.00
None
0.00
Cue Health Inc.
SOLEShares8.98M
TypeSH
Market value$1.70M
0.23%
Sole
8.98M
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$1.39M
0.19%
Sole
326.81K
Shared
0.00
None
0.00
Aadi Bioscience, Inc.
SOLEShares526.33K
TypeSH
Market value$1.23M
0.17%
Sole
526.33K
Shared
0.00
None
0.00
GeneDx Holdings Corp.
SOLEShares103.60K
TypeSH
Market value$945.9K
0.13%
Sole
103.60K
Shared
0.00
None
0.00
AtriCure Inc.
SOLEShares26.80K
TypeSH
Market value$815.2K
0.11%
Sole
26.80K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alpine Immune Sciences, Inc.SOLE | COM | 8.32M | SH | $329.72M 44.22% | 8.32M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 5.46M | SH | $239.64M 32.14% | 5.46M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 2.10M | SH | $33.09M 4.44% | 2.10M | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 129.07K | SH | $17.72M 2.38% | 129.07K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.96M | SH | $17.70M 2.37% | 4.96M | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 869.79K | SH | $16.42M 2.20% | 869.79K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 65.77K | SH | $11.70M 1.57% | 65.77K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 347.83K | SH | $11.08M 1.49% | 347.83K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $10.27M 1.38% | 4.45M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 850K | SH | $9.03M 1.21% | 850K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COM | 166.60K | SH | $8.37M 1.12% | 166.60K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 157.96K | SH | $7.39M 0.99% | 157.96K | 0.00 | 0.00 |
10x Genomics, Inc.SOLE | CL A COM | 195.84K | SH | $7.35M 0.99% | 195.84K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 94.04K | SH | $6.59M 0.88% | 94.04K | 0.00 | 0.00 |
LEGEND BIOTECH CORP-ADRSOLE | ADR | 86.36K | SH | $4.84M 0.65% | 86.36K | 0.00 | 0.00 |
MERUS NVSOLE | COM | 101.80K | SH | $4.58M 0.61% | 101.80K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $4.05M 0.54% | 515.55K | 0.00 | 0.00 |
Cue Health Inc.SOLE | COM | 8.98M | SH | $1.70M 0.23% | 8.98M | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $1.39M 0.19% | 326.81K | 0.00 | 0.00 |
Aadi Bioscience, Inc.SOLE | COM | 526.33K | SH | $1.23M 0.17% | 526.33K | 0.00 | 0.00 |
GeneDx Holdings Corp.SOLE | COM CL A | 103.60K | SH | $945.9K 0.13% | 103.60K | 0.00 | 0.00 |
AtriCure Inc.SOLE | COM | 26.80K | SH | $815.2K 0.11% | 26.80K | 0.00 | 0.00 |